Abberant crypt foci - Importance in colorectal carcinogenesis and expression of p53 and mdm2: A changing concept

Digestive Diseases and Sciences

Volumn 53, Issue 8, 2008, Pages 2183-2188

  Das, Prasenjit ^a,b   Jain, Deepali ^a   Vaiphei, Kim ^a   Wig, J D ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Aberrant crypt foci; Dysplastic; Hyperplastic; mdm2 protein; p53

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

ABERRANT CRYPT FOCI; ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; COLON DISEASE; COLON RESECTION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PREVALENCE; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INDIA; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 46449089773     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-0115-8     Document Type: Article

References (38)

1. Bird RP (1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 30:147-151
2. Corpet DE, Tache S (2002) Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency. Nutr Cancer 43:1-21
3. Corpet DE, Pierre F (2003) Point: from animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev 12:391-400
4. Takayama T, Katsuki S, Takahashi Y, Ohi M, Nojiri S, Sakamaki S, Kato J, Kogawa K, Miyake H, Niitsu Y (1998) Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 339:1277-1284
5. Cecilia M, Fenogilo P, Stemmerman GN (1999) Gastrointestinal pathology plus: an atlas and text, 2nd edn. Lippincott Williams & Watkins, Baltimore
6. Odez OD, John GR, James MC (2004) Surgical pathology of the GI tract, liver, biliary tract and pancreas. 1st edn. Saunders, Philadelphia
7. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87:159-170
8. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767
9. Lane DP (1999) Exploiting the p53 pathway for cancer diagnosis and therapy. Br J Cancer 80:1-5
10. Terry MB, Neugut AI, Mansukhani M, Waye J, Harpaz N, Hibshoosh H (2003) Tobacco, alcohol, and p53 overexpression in early colorectal neoplasia. BMC Cancer 6:29
11. Amundsen SA, Myers TG, Forance AJ Jr (1998) Roles of p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene 17:3287-3299
12. Soong R, Robbins PD, Dix BR, Grieu F, Lim B, Knowles S, Williams KE, Turbett GR, House AK, Iacopetta BJ (1996) Concordance between p53 protein over expression and gene mutation in a large series of common human carcinomas. Hum Pathol 227:1050-1055
13. Renehan AG, O'Dwyer ST, Haboubi NJ, Potten CS (2002) Early cellular events in colorectal carcinogenesis. Colorectal Dis 4:76-89
14. Soussi T (2000) p53 antibodies in the sera of patients with variant types of cancers: a review. Cancer Res 60:1777-1778
15. Moxon D, Raza M, Kenney R, Ewing R, Arozullah A, Mason JB, Carroll RE (2005) Relationship of aging and tobacco use with the development of aberrant crypt foci in a predominantly African-American population. Clin Gastroenterol Hepatol 3:271-278
16. Brabletz T, Kirchner T (2003) Morphogenetic aspects of colorectal cancer. Pathology 24:44-48
17. Sengupta A, Ghosh S, Bhattacharjee S, Das S (2004) Indian food ingredients and cancer prevention - an experimental evaluation of anticarcinogenic effects of garlic in rat colon. Asian Pac J Cancer Prev 5:126-132
18. Ishizuka S, Ito S, Onuma M, Kasai T, Aoyama Y, Hara H (1999) Ingestion of sugar beet fiber enhances irradiation-induced aberrant crypt foci in the rat colon under an apoptosis-suppressed condition. Carcinogenesis 20:1005-1009
19. Yoshimi N, Morioka T, Kinjo T, Inamine M, Kaneshiro T, Shimizu T, Suzui M, Yamada Y, Mori H (2004) Histological and immunohistochemical observations of mucin-depleted foci (MDF) stained with Alcian blue, in rat colon carcinogenesis induced with 1,2-dimethylhydrazine dihydrochloride. Cancer Sci 95:792-797
20. Mori H, Hata K, Yamada Y, Kuno T, Hara A (2005) Significance and role of early-lesions in experimental colorectalcarcinogenesis. Chem Biol Interact 155:1-9
21. Roncucci L, Stamp D, Medline A, Cullen JB, Bruce WR (1991) Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 22:287-294
22. Hurlstone DP, Karajeh M, Sanders DS, Drew SK, Cross SS (2005) Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia. Am J Gastroenterol 100:1283-1289
23. Yamada Y, Yoshimi N, Hirose Y, Kawabata K, Matsunaga K, Shimizu M, Hara A, Mori H (2000) Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res 60:3323-3327
24. Caderni G, Femia AP, Giannini A, Favuzza A, Luceri C, Salvadori M, Dolara P (2003) Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats:correlation with carcinogenesis. Cancer Res 63:2388-2392
25. Siu IM, Robinson DR, Schwartz S, Kung HJ, Pretlow TG, Petersen RB, Pretlow TP (1999) The identification of monoclonality in human aberrant crypt foci. Cancer Res 59:63-6
26. Thorup I (1996) Aberrant crypt foci in the colo-rectal mucosa as reliable markers of tumor development with special reference to histomorphological and immunohistochemical characterization of aberrant crypt foci in rats. National Food Agency of Denmark, Copenhagen
27. Luebeck EG, Moolgavkar SH (2002) Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci USA 99:15095-15100
28. Yuan P, Sun MH, Zhang JS, Zhu XZ, Shi DR (2001) APC and K-ras gene mutation in aberrant crypt foci of human colon. World J Gastroenterol 7:352-356
29. Wargovich MJ, Chang P, Velasco M, Sinicrope F, Eisenbrodt E, Sellin J (2004) Expression of cellular adhesion proteins and abnormal glycoproteins in human aberrant crypt foci. Appl Immunohistochem Mol Morphol 12:350-355
30. Furihata T, Kawamata H, Kubota K, Fujimori T (2002) Evaluation of the malignant potential of aberrant crypt foci by Immunohistochemical staining for β-catenin in inflammation-induced rat colon carcinogenesis. Int J Mol Med 9:353-358
31. Yamashita N, Minamoto T, Onda M, Esumi H (1994) Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon. Jpn J Cancer Res 85:692-698
32. Yamashita N, Minamoto T, Ochiai A, Onda M, Esumi H (1995) Frequent and characteristic K-ras activation in aberrant crypt foci of colon. Is there preference among K-ras mutants for malignant progression? Cancer 75:1527-1533
33. Augenlicht LH, Richards C, Corner G, Pretlow TP (1996) Evidence for genomic instability in human colonic aberrant crypt foci. Oncogene 12:1767-1772
34. Stopera SA, Bird RP (1993) Immunohistochemical demonstration of mutant p53 tumor suppressor gene product in aberrant crypt foci. Cytobios 73:73-88
35. Otori K, Sugiyama K, Hasebe T, Fukushima S, Esumi H (1995) Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation. Cancer Res 55:4743-4746
36. Luo L, Shen GQ, Stiffler KA, Wang QK, Pretlow TG, Pretlow TP (2006) Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer. Carcinogenesis 27:1153-1159
37. Juven GT, Oren M (1999) mdm2: the ups and downs. Mol Med 5:794-799
38. Bird RP, McLellan EA, Bruce WR (1989) Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer. Cancer Surv 8:189-200